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The purpose of this study was to evaluate the in vivo 
state of both branches of the autonomic nervous system 
in children with chronic atopic dermatitis. 
In 15 patients, age 4 to 11, the following parameters 
were analyzed: (1) basal plasma levels of epinephrine, 
norepinephrine, and dopamine; (2) poststimulation 
(standing and i.v. furosemide administration); (3) basal 
urinary excretion of epinephrine, norepinephrine, and 
vainillin mandelic acid; (4) 30 min postfurosemide ad-
ministration; (5) parotid secretory response to intraoral 
0.1 M citric acid: flow rate, saliva pH, and concentrations 
of bicarbonate, chlorides, inorganic phosphates, total 
protein, and amylase activity. 
No differences in plasma and urinary basal levels of 
the catecholamines were observed. In response to stand-
ing, plasma norepinephrine from atopic children showed 
a greater increase than that seen in normal healthy 
children. From the salivary factors studied, no differ-
ences were found in parotid flow-rate, bicarbonates, 
chlorides, and inorganic phosphates. Protein concentra-
tion as well as amylase activity were significantly de-
creased in children with atopic dermatitis. These find-
ings suggest that in atopic dermatitis, the P-sympathetic 
mediated responses are impaired; on the other hand, 
parasympathetic mediated responses remain preserved. 
Although numerous studies have been reported on the etiol-
ogy of atopic dermatitis, the cause of this disease remains 
unknown. Various reports on abnormal autonomic responses 
such as white dermographism [1], abnormal reaction to acetyl-
choline [2], as well as to epinephrine [3] and retention of 
norepinephrine in the skin [ 4] suggest that distw-bances of the 
autonomic nervous system could play a role in th e physiopa-
thology of atopic dermatitis. Fw-ther evidence of the involve-
ment of the sympathetic branch in this disease may also· be 
concluded by the following findings: low blood pressure dw-ing 
exacerbation of the disease [5], delayed accomodation to 
changes in environmental temperature [6,7], a flat glucose 
tolerance cw-ve [5] and distw-bances in sweating [8,9]. The 
finding that propranolol modifies most of the above-mentioned 
abnormal responses in autonomic effectors such as arterials, 
pilomotor muscles, and sweat glands [10], has been interpreted 
as a dysfunction of the (3 adrenergic receptors in th e pathogen-
esis of this disease. In t his respect, Szentivanyi [11] proposed 
that the various abnormalities of atopic diseases could be 
explained by a partial blockade of p adrenergic receptor sites in 
the respective target cells. Thus, a adrenergic stimulation as 
suggested by the increased sensitivity of the vascular smooth 
muscles or the increased sensitivity to responses mediated by 
muscarinic receptors of th e sweat glands, may be explained by 
a counterbalancing effect due to p adrenergic receptors mal-
function . Studies in vitro with epidermis showed that (3 ad.I·en-
ergic agonists failed to evoke the normal inhibition of mitosis in 
basal cells in atopic dermatitis patients [12]. On the other hand, 
there are findings showing no differences between normal and 
atopic epidermis in th e intracellular cAMP accumulation in 
vitro in response to isoproterenol [12]. Moreover, no changes 
were found in the activities of either phosphodiesterase and 
proteinkinase [13,14], although there is some evidence that the 
latter may be altered in atopic dermatitis [15]. With respect to 
these results it should be taken into account that partial block-
ade of (3 receptors induce changes in its sensitivity, but not in 
the effector 's maximal response [16]. The above observations 
might be-explained through th e use of supramaximal doses of 
isoproterenol. This interpretation is supported by results de-
scribed in the same study: lymphocytes from atopic patients 
showed a decreased response in their intracellular levels of 
cAMP upon stimulation with isoproterenol, while the response 
to PGE, was similar to control values [12]. Thus, the diminished 
(3 adrenergic response does not obey to alterations in the 
reaction sequences following activation of adenylatecyclase and 
leading to the effector's response. It is, however, most likely due 
to changes at the receptor sites. 
In the present study th e in vivo state of autonomic nervous 
activity was further analyzed in order to reevaluate the involve-
ment of (3 receptors in atopic dermatitis. To this effect, plasma 
norepinephrine (NE), epinephrine (E) , and dopamine (DA), 
w-inary NE, E, and vainillin mandelic acid (VMA), and parotid 
secretion after indirect stimulation were evaluated. 
MATERIALS AND METHODS 
Thirty-six children age 4 to 11 were studied: 15 children with chronic 
atopic dermatitis; 6 children with some combined stigmas of atopic 
disease (Group 3); and 15 controls. Diagnosis of atopic dermatitis was 
made according to the criteria of Hanifin and Lobitz (17]. 
Although children belonging to group 3 did not respond to these 
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Catecholam.in.es Studies 
Basal stimulated plasma, norepinephrine (NE) , epinephrine (E) and 
total dopamine (DA), and urinary catecholamine (CA) levels, were 
measured. Basal samples were taken in the supine position; blood was 
drawn through an indwelling intravenous needle when both pulse rate 
and blood pressure remained stable, which occw-red between 20 and 30 
min after venipuncture. Stimulated catecholamines were measured in 
plasma of patients after a 5-min period of standing. In the same way, 
plasma catecholamines were measured in 5 healthy children and 8 
patients with atopic dermatitis, 10 and 15 min after furosemide admin-
istration (0.5 mg/ kg/ iv) . 
494 CRESPI ET AL 
Urinary excretion of NE, E, and VMA were evaluated from a urine 
specimen collected over 24 hr, and also in a sample taken 30 min 
postfurosemide stimulation. 
P lasma NE, E, and total DA were assayed by the radioenzymatic 
method [18], as modified in our laboratory [19]. Urinary levels of NE 
and E were measured fluorimetrically as originally described by von 
Euler and Lishajko [20] and subsequent ly modified by Donoso, Bis-
cardi, and Wasserman [21]; VMA was assayed by the method of P isano, 
Crou t, and Abraham [22]. 
Parotid R esponse 
The functional capacity of the parotid gland was studied by measur-
ing the secretory flow rate in response to stimulation with in traoral 0.1 
M citric ac id. For this purpose samples of parotid sal iva were collected 
unilaterally from children belonging to the 3 experimental groups using, 
the vacuum cup described by Shannon, Prigmore, and Chauncey [23]. 
In all cases, medication was suspended for at least 7 days before the 
functional studies, which were performed between 7:00 and 8:00 AM 
before breakfast. Each patient stimulated his oral mucosa with 3 mi. 
0.1 M citric acid solut ion without swallowing for 30 seconds. This 
procedure was repeated twice for 30 seconds, fo llowed by 30 seconds 
rest on each occasion. The samples of parotid saliva were collected in 
calibrated tubes. Stimulated parotid saliva shows circadian rhythms in 
its flow rate and also in the concentration of its inorganic and organic 
components [24 ]. In order to minimize these normal physiological 
variables, parotid flow rate measurements were standardized according 
to Dawes [25]. 
In addition, in the sam e samples, saliva pH was immediately deter-
mined on an Accumet 610 pH-meter. Flow rate was measured and 
expressed in ml/min. Samples were stored at 0°C. Total protein con-
cen tration was evaluated according to Lowry et al [26]; amylase activity, 
by the starch-iodine method [27]; results are expressed in amylolytic 
units/100 rnl; bicarbonate concentration in saliva was measm ed by 
Segal's titrimetric method as modified by Henry [28], using PSP 
(phenol red) as indicator; values a1·e expressed in mEq/1.; chlorides, by 
Schales and Schales [29] titrimetric method; inorganic phosphates (Pi) 
were spectrophotometrically determined in supernat~o1 nts of parotid 
saliva (1/5) in 10% trichloroacetic acid [30]. 
Statistical Analyses 
The mean and SEM of the results were calculated for all groups. 
T he signific_ance of differences between means was evaluated with 
S tudent's t test and probability with the T able of Fisher and Yates 
[31]. p < 0.05 was considered significant. 
RESULTS 
A. Basal Plasma and Urinary CA Levels 
NE, E, and DA basal plasma values did not differ in the 3 
experimental groups studied (Table). Similarly, no statistically 
significant differences were found when basal urinary levels of 
NE, E, and VMA of children with a topic dermatitis (n=10) 
were compared with control values (n=15) . 
B. Effects of Upright Position 
Figure 1 shows that assumption of an upright posture in 
normal chilch·en induced an increase in the plasma NE and E 
levels,. while no differences were obtained in DA levels. A 
similar increase in the response to the standing position was 
obtained in those patients belonging to group 3. Patients with 
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atopic dermatit is showed a greater increase in their plasma NE 
levels than those in the above-mentioned groups. Thus, plasma 
NE increased 37.6 ± 8.46% and 32.3 ± 10.60% in controls and 
group 3 respectively, while the increase observed in children 
with atopic dermatitis was 91.8 ± 21.48% (p < 0.025) . No 
significant differences in the response to standing were observed 
in plasma E and DA among the 3 groups (Fig 1) . 
In response to upright position, control children (n=15) in-
creased their pulse rate in 18.1 ± 2.86 beats/min; this increase 
was significantly lower (p < 0.05) in atopic dermatitis patients 
(10.0 ± 2.50 beats/min, n=10) . 
C. Effects of Furosemide 
After drug administration, both NE and E plasma values 
were further increased over standing levels. The maximal incre-
ment appeared between 10 and 15 min after i.v. fmosemide, 
this increase being similar in magnitude in both experimental 
groups studied, (controls: NE 31.8 ± 12.5%, (n=5); atopic der-
matitis: 24.3 ± 13.28%, (n=8). 
Figure 2 shows that after furosemide the urinary excretion of 
NE, E, and VMA were significantly increased when r elated to 
basal levels in both groups (p < 0.001). 
Parotid Response 
Figure 3 shows that the parotid secretory response elicited 
after stimulation with citric acid was 0.62 ± 0.20 ml/ min in 
atopic dermatitis patients, a value which was not different from 
those obtained in controls and group 3 patients. 
The saliva pH of all children were in t\le sam e range (7.54 ± 
0.39 in atopic children; 7.71 ± 0.28 in group 3 and 7.79 ± 0.44 in 
controls). Similarly, in atopic patients, bicarbonate and chloride 
concentration (mEq/1) and Pi (mg%) did not differ from values 
obtained in controls or group 3. On the other hand, in atopic 
patients the total protein concentration in saliva (188 ± 25.93 
mg%) was significantly decreased (p < 0.025) when compared 
with that of healthy children (320 ± 48.23 mg%). It should be 
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FIG 1. Plasma catecholamines after standing, D normals, n= 15, 
IW<:I : atopic dermatitis, n=10, §: group 3, n=5. B, basal; S, after 
standing for 5 min. ln ordinates NE, E, and DA ru·e expressed in pg/ ml. 
• p < 0.025 when compared to increase in percentage found in either 
controls or children belonging to group 3. 
Basal plasma and urinary catecholamine levels in nmmal children (controls), children with atopic dermatitis, and children who did not meet 
the cri teria of Hanifin and Lobitz (group 3) 
-------------------------------------Basal Plasma Levels Basal urinary levels 
NE E DA NE E VMA (pg/ml ) (pg/ ml) . (pg/ ml) (ug/24 hr) (ug/24 hr) (mg/ 24 hr) 
Controls 240 ± 39.4 149 ± 23.3 1066 ± 137.8 34.1 ± 4.32 1.7 ± 0.48 4.3 ± 0.72 (n = 15) 
Atopic dermatitis 203 ± 33.8 100 ± 12.5 1202 ± 144.0 30.9 ± 3.84 1.9 ± 0.72 4.1 ± 0.72 (n = 10) 
Group 3 201 ± 46.0 134 ± 36.5 1081 ± 217.9 ND" ND ND (n = 5) 
"ND: Not determined. 
Valu es are mean ± SEM of n experiments. 
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F1c 2. Effects of furosemide administration (0.5 mg/ kg i.v. ) on uri-
nary NE, E, and VMA. NE and E values m·e expressed in ug/ hr; VMA 
in mg/ hr. 0: normal, n=8, ~:atopic dermatitis, n=5. The bar on 
t he left indicates basal values; the bar on the right catecholamine levels 
30 min after furosemide administration. • p < 0.001 when compared to 
its own basal levels. 
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FIG 3. Flow rate (ml min- '); pH; -Hc o ,., (mEq/ 1); Pi (mg 100 ml- ') 
and Cr, (mEq/ 1) of pm·otid saliva after citric acid 0.1 M stimulation. 
c:=J : normal, n= l5, ~: atopic dermatitis, n= l5 and E:S: group 3, 
n=6. Values are mean ± SEM of n experiments. 
noted t hat the total protein concentration of patients belonging 
to group 3 was similar to controls (354 ± 32.69 mg%). Amylase 
a ctivity was found to be significantly decreased in children with 
atopic dermatitis (p < 0.001) , (from 244,000 ± 33,093 in con~rols 
to 89,786 ± 18,349 amylolytic units/ 100 ml). No such decrease 
was observed in pa tients of group 3 (271,333 ± 35,722) (Fig 4). 
.......... 
(j) 
...... 
·c: 
:::J 
>-I ~ 
E :~ ~ 
0 u 
0 0 
....-
<lJ 0"1 (j) E 0 
~ >-c 
"Qj E 
--
<( 0 
'-
0.... 
FIG 4. Protein concentration (mg 100 ml- 1) and amylase activity (in 
amylolytic units/ 100 ml) in parotid saliva from D: controls, n= l5, 
~: atopic dermatitis, n= l5 and §:group 3, n=6. Values are mean 
± SEM of n experiments. • p < 0.025; • • p < 0.001 when compm·ed 
wi th control va lues. 
DISCUSSION 
Assessment of basal levels of plasma NE, E, and DA by a 
radioenzymatic method and urinary catecholamines ar e sensi-
tive indicators for evaluating sympathoadrenal medullary func-
tion (32]. Since the values of plasma catecholamines in clu onic 
atopic children did not differ from those obtained in controls, 
it can be concluded tha t the repor ted reduced responsiveness 
of adrenergically innervated organs, does not obey changes in 
sympathetic tone or dysfunction of adrenal medulla. However, 
a previous report shows tha t plasma NE levels are decreased in 
this disease (33]. This difference can be attribu ted either to the 
fact that the above reported study was performed on youngsters 
wit h extensive acute dermatit is, and/ or to the use of different 
methods for analyzing plasma NE levels. The normal values of 
basal ur inal"y NE and VMA levels found in chronic atopic 
childl·en lend support to the interpreta tion that basal sympa-
thetic tone is not altered. Plasma catecholamine levels were 
also measured after standing, in order to further elucidate the 
mechanism by which adrenergic-mediated responses a1·e re-
duced in atopic pa tients. This refl ex indicates a primary fu nc-
tion of t he sympathetic system in maintenance of blood pressure 
between supine and upright positions (34). Under this physio-
logical stimulus, the heart rate increase in chm nic atopic chil -
dren was significantly lower than that observed in controls or 
group 3. A similar reduction in pul e rate has been described in 
asthmatic patients [11]. This phenomenon can be attributed to 
a reduced ,8-caTdiac Tesponse induced by the baTo-receptor 
reflex. The greater increase in plasma NE levels observed in 
atopic childl·en in r esponse to standing may be a compensatory 
mechanism to maintain normal blood pressure. Standing stim-
ulus in atopic children did not induce a maximal response in 
NE plasma levels considering the further increase obtained 
after phaTmacological stinmlation with nuosemide. In addition, 
the fact that pharmacological stimulation increased urinary 
NE, E, and VMA levels to the same extent in both atopic 
pa tients and controls, suggests that volume receptors involved 
in this homeostatic r eflex remain unaltered in the former group. 
S ince both baro and volume reflexes do not seem to be modified 
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in atopic disease, the decreased responsiveness in heart rate 
after physiological stimulation prompted us to further analyze 
the involvement of f3 receptors. 
The parotid gland is a suitable model for studying the auton-
omically mediated responses, since secretion of saliva depends 
mainly on the activation via mouth receptors and reflexes of 
the gland's cholinergic muscarinic and a and f3 adrenoreceptors 
[35). Another advantage of this model is that no basal secretion 
occurs if not evoked by nervous stimuli [36]. Recent studies 
show that salivary amylase secretion depends on activation of 
f3 receptors while salivary fluid and electrolytes are mediated 
through activation of either muscarinic and/or o:-adrenorecep-
tors [37). In patients with atopic dermatitis, parotid secretory 
response elicited after stimulation with intraoral citric acid did 
not differ from control values. Similar phenomena were ob-
served in those parameters which are mainly dependent on 
parasympathetic nerve stimulation, such as saliva pH, bicar-
bonate, chloride, and phosphate concentration. Thus, parasym-
pathetic activity does not seem to be involved in atopic diseases. 
This conclusion is further supported by findings that neither 
flow rate, saliva pH, nor bicarbonate and inorganic phosphates 
concentration, are modified in chronic asthmatic children [38). 
Moreover, these findings not only reflect the integrity of the 
autonomic centers regulating salivary secretion but also exclude 
a primary deficiency of the parotid gland. 
In atopic dermatitis, on the other hand, the parotid f3 me-
diated response, amylase activity as well as protein concentra-
tion, showed a remarkable functional impairment. This desen-
sitization of f3 adrenoreceptors in a target organ where normal 
o: and cholinergic muscarinic responses coexist, firmly support 
the f3 adrenergic theory and suggest that in this disease, sub-
sensitivity of general f3 receptors is a fundamental characteristic 
of atopy. A similar desensitization of f3 adrenoreceptors has 
been demonstrated experimentally [39) and is also described in 
patients with bronquial asthma [ 40). 
Whether this chronic dysfunction of f3 adrenoreceptors may 
induce a higher sympathetic nervous activity by feedback 
mechanism does not seem to be clear, since basal plasma and 
urinary catecholamines in atopic children were normal. With 
respect to these findings it should be taken into account that 
when in vivo studies are performed to detect abnormalities in 
autonomically innervated effectors, responses measured could 
be masked by physiological homeostatic mechanisms. However, 
the mechanisms which could maintain homeostasis in the basal 
state do not seem to be efficient enough when stimulated 
judging from the higher NE plasma levels found in atopic 
children after standing. Although it cannot be ruled out that 
higher increase in NE levels is related to greater sympathetic 
nervous activity (increased release of NE; enhanced delivery of 
catecholamines into circulation; reduction in neuronal or extra-
neuronal uptake; reduction in its metabolism), our findings 
suggest again that, chronologically, f3 adrenoreceptors subsen-
sitivity seems to be the primary defficiency in this disease. This 
is supported by recent studies indicating that NE and E are 
cleared through mechanisms modulated by f3 adr!=!noreceptors 
[ 41], and that lymphocytic membranes from atopic patients 
show a reduction in f3 adrenoreceptors [ 42). 
REFERENCES 
1. Ramsay C: Vascular changes accompanying white dermographism 
and delayed blanche in atopic dermatitis. Br J Dermatol 81:37-
42, 1969 
2. Scott A: Acetylcholine in normal and diseased skin. Br J Dermatol 
74:317-322, 1962 
3. Lobitz WC Jr., Campbell CJ: Physiologic studies in atopic derma-
titis (disseminated neurodermatitis): I. The local cutaneous re-
sponse to intradermally injected acetylcholine and epinephrine. 
Arch Dermatol 67:575-589, 1953 
4. Solomon LM, Wentzel HE, Tulsky E: The physiological disposition 
of C14-norepinephrine in patients with atopic dermatitis and 
other dermatoses. J Invest Dermatol 43:193-200, 1964 
Vol. 78, No. 6 
5. Baer R L: Atopic dermatitis. Med Clin N Amer 43:770-775, 1959 
6. Eyster WH Jr., Roth GM, Kierland RR: Studies on the peripheral 
vascular physiology of patients with atopic dermatitis. J Invest 
Dermatol 18:37-46, 1952 
7. Weber RY, Roth GM, Kierland RR: Further contributions to the 
vascular physiology of atopic dermatitis. J Invest Dermatol 
24:19-30, 1955 
8. Pillsbury DM, Shelley WB, Kligman AM: Dermatology. Philadel-
phia, W.B. Saunders Co., 1956, pp FF 
9. Warndorff JA: The response of the sweat gland to acetylcholine in 
atopic subjects. Br J Dermatol 3:306-311, 1970 
10. Hemels HGWM: The effect of propranolol on acetylchol ine induced 
sweat gland response in atopic and non atopic subjects. Br J 
Dermatol 83:312-314, 1970 
11. Szentivanyi A: The beta adrenergic theory of the atopic abnormal-
ity in bronquial asthma. J Allerg 42:203-232, 1968 
12. Reed Ch E, Busse WW, Lee PT: Adrenergic mechanisms and the 
adenyl cyclase system in atopic dermatitis. J Invest Dermatol 
67:333-338, 1976 
13. Holla SW, Hollman EP, Mier PD, van der Starr WJ BM, Ursel-
mann E, Warndorff JA: Adenosin 3', 5'-ciclic monophosphate 
phosphodiesterase in skin. II Levels in atopic dermatitis. Br J 
Dermatol 86:147-149, 1972 
14. Mier PD, van der Hurk J, Holla SWJ, Hollman EPMJ, Porter JE, 
Weemers MBM: Cyclic 3', 5' adenosine monophosphate depen-
dent proteinkinase of skin: II Levels in atopic dermatitis and 
psoriasis. Br J Dermatol 87:577-880, 1972 
15. Kumar R, Solomon LM, Schl'eckenberger A, Cobb JC: An evalua-
tion of adenosine 3,5-cyclic monophosphate dependent protein-
kinase activity in atopic dermatitis. J Invest Dermatol 65:522-
524, 1975 
16. Rimon G, Hanski E, BraunS, Levitzki A: Mode of coupling between 
hormone receptors and adenylate cyclase elucidated by modula-
tion of membrane fluidity. Nature 276:394-396, 1978 
17. Hanifin JM, Lobitz WC Jr.: Newer concepts of atopic dermatitis. 
Al'ch Dermatol 113:663-670, 1977 
18. Da Prada M, Ziircher G: Simultaneous rapioenzymatic determina-
tion of plasma and tissue adrenaline, noradrenaline and dopamine 
within the fentomole range. Life Sci 19:1161-1174, 1976 
19. Armando I, Levin G, Barontini M: Catecolaminas plasmaticas en 
sujetos normales:falta de respuesta al LH-RH. In Abstracts of V 
Congreso Al'gentino de Endocrinologia y Metabolismo. Bal·i l-
oche. Al·gentina, 1979, p 54. 
20. von Euler US, Lishajko F: The estimation of catccholamines in 
urine. Acta Physiol Scand 45:122-132, 1959 
21. Donoso AO, Biscardi AM, Wasserman GF: Valoracion diferencial 
de adrenalina y noradrenalina con un metodo fluorimetrico com-
binado. Medicina 25:169-174, 1975 
22. Pisano JJ, Crout RJ, Abraham D: Determination of 3-methoxy-4-
hydroxymandelic acid in urine. Clin Chern Acta 7:285-291, 1962 
23. Shannon IL, Prigmore JR, Chauncey HH: Modified Carlson-Crit-
tenden device for the collection of parotid fluid. J Dental Res 
41:778-783, 1962 
24. Dawes C: Circadian rhythms in human salivary flow rate and 
composition. J Physiol 220:529-545, 1972 
25. Dawes C: The effects of flow rate and duration of stimulation on 
the concentrations of protein and the main electrolytes in human 
submandibular saliva. Arch Oral Bioi 18:887-895, 1974 
26. Lowry OH, Rosenbrough NJ , Farr AL, Randall RJ: Protein mea-
surement with the Folin phenol reagent. J Bioi Chern 193:265-
275, 1951 
27. Smith BW, Roe JH: A photometric method for the determination 
of a-amylase in blood and w·ine with use of the starch-iodine 
color. J Bioi Chern 179:53-58, 1949 
28. Henry RJ: Clinical Chemistry Principles and Techniques. New 
York, Harper and Row, 1964, pp. 462-464 
29. Schales 0, Schales SS: A simple and accurate method for the 
determination of chloride in biological fluids. J Bioi Chern 
140:879-883, 1941 
30. Chen PS, Toribara T, Warner H: Microdetermination of phospho- · 
rus. Analyt Chern 28:1756-1758, 1956 
31. Fischer RA, Yates F: Statistical Tables for Biological Agricultural 
and Medical Research, 4th ed. Edinbmg Oliver and Boyd, 1939, 
Table 39 
32. Cryer PE: Isotope derivative measw·ement of plasma norepineph-
rine and epinephrine in man. Diabetes 25:1071-1082, 1976 
33. Solomon LM, Wentzel HE: Plasma catecholamines in atopic der-
matitis. J Invest Dermatol 4:401-404, 1963 
34. Kopin IJ, Lake RC, Ziegler M: Plasma levels of norepinephrine. 
Ann Intern Med 88:671-680, 1978 
35. Garrett JR: Neuro-effector sites in salivary glands, Oral Physiology. 
Edited by N Emmelin, Y Zotterman. Oxford, New York, Perga-
mon Press 1972, p 83 
36. Emmelin N: Control of salivary glands, Oral Physiology (Edited by 
N Emmelin, Y Zotterman. Oxford, Pergamon Press, 1972, pp 1-
14 
37. Stefano FJE, Perec CJ: Denervation supersensitivity in sal ivary 
June 1982 CATECHOLAMINES AND PAROTID SECRETION IN ATOPIC DERMATITIS 497 
glands. Trends Pharmacol Sci 2:107-109, 1981 
38. Hyyppii T, Paunio K: Oral health and salivary factors in children 
with asthma. Proc Finn Dent Soc 75:7-10, 1979 
39. Mukherjee C, Caron MG, Lefkowitz RJ: Catecholamine-induced 
subsensitivi ty of adenilate cyclase associated with loss of beta 
adrenergic receptor binding sites. Proc Natl Acad Sci 72:1945-
1949, 1975 
40. Conolly ME, Greenacre JK: The lymphocyte beta-adrenoceptor in 
normal subjects and patients with bronchial asthma. J Clin Invest 
58:1307-1316, 1976 
41. Cryer PE, Rizza RA, Haymond MW, Gerich JE: Epinephrine and 
norepinephrine are cleared through beta-adrenergic, but not 
a lpha-adrenergic, mechanisms in man. Metabolism 29: 1114-1118, 
1980 
42. Szentivanyi A, Heim O, Schiltze P, Szentivanyi J: Adrenoceptor 
binding studies with eH) dihydroalprenolol and eH) dihydroer-
gocryptine on membranes of lymphocytes from patients with 
atopic disease. Acta Dermatovener (Stockh) Suppl92:19-21 , 1980 
Announcement 
Cambridge University Medical School will hold a course in the Progress in the Biological Sciences in 
Relation to Dermatology. The sixth 5-year course aimed at bringing clinical dermatologists and others 
up-to-date with Progress in the Biological Sciences in Relation to Dermatology will be held in Churchill 
College, Cambridge, England, on September 26-30, 1983. Fmther information may be obtained from the 
Administrator, Postgraduate Medical Centre, Addenbrooke's Hospital, Cambridge, England (Tel: Cam-
bridge (0223) 212216) . 
